Evidence map›Paper›PMID 23329495›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2013

Production of CD4⁺ and CD8⁺ T cell hybridomas.

David H Canaday

Erratum issuedAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Optimal murine CD4Nature communications · 2026
    Article
  2. Article
  3. Article
  4. Frontiers in endocrinology · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

David H CanadayDivision of Infectious Disease, Case Western Reserve University, Cleveland, OH, USA. dxc44@case.edu.

Funding

Mechanisms of increased susceptibility to TB in HIV-Infected individualsR01AI080313 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI CANADAY, DAVID H · 2010 to 2013
$2.0M
Predictors of Immunologic Failure in Older AdultsI01CX000249 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI CANADAY, DAVID H · 2009 to 2012
–
CSRD VA I01 CX000249NIAID NIH HHS AI080313NIAID NIH HHS R01 AI080313
6 · The paper itself

Abstract

T cell hybridomas are very useful tools to investigate antigen presenting cell (APC) function. They were developed based on the fusion technology that led to monoclonal antibody section. Antigen-specific primary T cells are generated and fused to an immortal thymoma line. Unfused thymoma cells are eliminated by engineered metabolic selection. Antigen-specific hybridomas are identified and may be characterized in detail. Primary T cells are preferable for studies of the regulatory mechanisms intrinsic to T cells, but for study of antigen presentation T cell hybridomas have advantages over primary T cell clones, including their relative uniformity, stability over time, and ready availability in large numbers for extensive antigen presentation experiments.

Indexed as

AnimalsAntigensCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell FusionCell SeparationClone CellsCryopreservationHybridomasImmunizationMiceAntigens

Identifiers

PMID23329495
PMCPMC4552323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.